Mustang Bio Announces Preclinical Data on Potency of its CAR T Cells in Glioblastoma Published in JCI Insight May 30, 2018
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain May 21, 2018
Checkpoint Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights May 10, 2018
Fortress Biotech Reports First Quarter 2018 Financial Results and Recent Corporate Highlights May 10, 2018
Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights May 03, 2018
Caelum Biosciences Submits Draft Registration Statement on Form S-1 to the Securities and Exchange Commission Apr 20, 2018
Checkpoint Therapeutics Reports Preclinical Data on BET Inhibitor CK-103 at the American Association for Cancer Research Annual Meeting Apr 18, 2018
